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Truth in Numbers
Along one wall ofJoseph K. Haseman's
office stands a floor-to-ceiling bookcase
lined with identical powder blue books.
These are Haseman's pride and joy: 500
technical reports representing rodent car-
cinogenicity assays conducted over the
past 20 years for the National Toxicology
Program (NTP). As director ofstatistical
consulting for the NIEHS, Haseman is
responsible for the statistical integrity of
studies done for the NTP as well as other
programs within the institute. His 30
years' experience in experimental design,
data analysis, and interpretation of exper-
imental findings has made him a valued
expert. "Joe Haseman has done more
than any other person to ensure that the
NTP rodent studies are evaluated in a
comprehensive, consistent, and objective
manner," says John Bucher, deputy
director of the NIEHS Environmental
Toxicology Program.
Haseman's specialty is extracting the
truth from the voluminous data pro-
duced by NTP bioassays. As the saying
goes, there are lies and there are damned
lies, and then there are statistics. Unless
one understands what they are seeing in
the numbers and is committed to objec-
tivity, it is just as possible to draw mis-
leading conclusions from tumor counts
as it is from other areas of statistical
analysis. Haseman analyzes data for 80
different NIEHS scientists covering all
aspects of environmental health, but his
principal focus has been on cancer
research, specifically on rodent bioassays.
Over the years, Haseman and col-
leagues have been involved in a number of
high-profile studies of potential carcino-
gens. These include studies on vitamin C,
sodium fluoride, talc, and electromagnetic
fields. These studies have identified a
number of chemicals, including benzene
and 1,3-butadiene (used in the manufac-
ture of synthetic rubber and certain
resins), as potent rodent carcinogens.
Epidemiology studies have since con-
firmed the carcinogenicity of these two
chemicals in humans as well.
Geting at theTth
NTP studies are designed to characterize
and evaluate the toxicologic and carcino-
genic potential of selected chemicals in
laboratory animals. In a typical study, 50
male and female rats and mice are
exposed to three different dosages of the
chemical of concern. A control group is
also monitored. After two years, a pathol-
ogist necropsies the animals and diag-
noses tumors at various sites. A statistician
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data for 80 different NIEHS scientists and has
helped produce over 500 technical reports,
which are used by regulatory agencies to per-
form risk assessments.
then evaluates the data to determine the
likelihood that any increased tumor inci-
dence is chemically related. Following
this evaluation, the research team then
characterizes the strength of the evidence
of the chemical's carcinogenicity ("clear
evidence," "some evidence," "equivocal
evidence," or `no evidence").
The procedure seems straightforward.
But assessing the true effect ofa chemical
is not simply a matter of counting
tumors; a statistician's knowledge of
background tumor rates and confound-
ing variables provides a key perspective in
this interpretive process. "Because of the
many tumor types and sites examined
and the use of multiple dosage groups
and sex-species combinations, statistical-
ly significant tumor increases can and do
occur by chance," Haseman says. "The
question then becomes how to take into
account the large number of statistical
comparisons being made."
NTP study teams do not directly per-
form risk assessments for the chemicals
they analyze. Rather, their findings are
written into reports-the infamous blue
books-which are then used by regulato-
ry bodies such as the U.S. Environmental
Protection Agency to perform these
assessments. Risk assessments may then
lead to regulations setting permissible
levels of exposure or to the chemical's
being banned altogether.
Each time NTP researchers analyze a
data set, the information is put into a
massive database. By analyzing this data-
base over the years, Haseman and his
colleagues have been able to estimate the
frequency with which false positive out-
comes may occur, and they take this into
account when interpreting experimental
findings. "Examples of why statistically
significant results may be discounted
include lack of a dose-response relation-
ship, an abnormally low concurrent con-
trol rate, or dosed-group tumor rates that
are within the normal control range,"
Haseman says. "Statistics is an important
tool, but you also have to use scientific
judgment in interpreting the statistical
findings."
By periodically reviewing the NTP
database, Haseman and colleagues have
also been able to observe and monitor
changes in tumor rates over time. Under-
standing what causes these changes can
lead researchers to take measures to
reduce the incidence of background
tumors and improve the health of the
animals as well as the accuracy of the
tests. For example, the researchers
observed that certain tumors, such as
liver tumors in mice, occur with greater
frequency in heavier animals. They also
noticed that over time, average body
weights of test animals were increasing,
contributing to a higher incidence of
background tumors and a reduction in
survival. In response to these findings,
NTP researchers changed the rodent diet
to reduce body weight and thus increase
survival and reduce the incidence of
background tumors.
Sometimes, exposure to suspected
carcinogens results in a decrease in tumor
rates. Here again, Haseman's extensive
knowledge of the NTP database led to a
discovery of one mechanism of action.
Observing a reduction among Fischer
344 rats of mononuclear cell leukemia
after exposure to a certain class ofchemi-
cals, Haseman dug back into the NTP
database and noticed a clear association
between a reduction in this illness and
damage to the animal's spleen. Haseman
consulted with NTP pathologist Mike
Ewell, who informed him that removal of
the spleen was known to reduce leukemia
rates in Fischer 344 rats. Subsequent
investigations showed.that the chemicals
of concern were damaging the rats'
spleens in a way that mimicked removal,
thereby reducing the incidence of
leukemia.
Blaing NewTrails
Haseman's periodic reviews of the NTP
database, written up and published in the
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journal Toxicologic Pathology, are highly
valued by other researchers in the field.
In 1997, as part ofits twentieth-anniver-
sary celebration, the journal recognized a
1984 article by Haseman and coauthors
James Huff and Gary
Boorman, "Use of His-
torical Control Data in
Carcinogenicity Studies in
Rodents," as one of the
10 most frequently cited
articles in the journal's n
history.
Recently, Haseman
and colleagues have been
refining the use of trans-
genic animals developed
at the NIEHS for carcino-
genicity studies. One of
the benefits of these ani-
mals is that they evidence
chemical-related carcino-
genic effects more quickly
than the strains used in the
standard rodent bioassay. Using
transgenic animals dramatically shortens
the time frame required for completing
the studies and reduces the number of
animals that must be used. Transgenic
mouse studies typically last only 6
months and usually use only 15-20 ani-
mals per group, compared with 2 years
and 50-60 animals per group for the
standard rodent bioassay.
However, the unique characteristics
of the transgenic animal have also
required new statistical methodologies.
For instance, for some transgenic lines,
the main tumor of interest is the skin
papilloma, which can be observed direct-
ly rather than requiring a necropsy. A
multiplicity of these skin papillomas can
occur within the same animal over time.
The appeal of transgenics. Transgenic mouse
require only one-third the number of animals, com
In a standard rodent bioassay, the end
point ofanalysis would be whether or not
the animal developed a tumor, but for a
transgenic mouse model, the end point of
analysis is how many tumors the animal
has and over what time period
they develop. To accurately
evaluate this response,
Haseman and colleague
David Dunson have devel-
oped new mathematical
models that take into
account both tumor multi-
plicity and the time course
oftumor occurrence.
Haseman is frequently
called upon to represent d the institute in evaluations
of new testing methods
such as the Frog Embryo
Teratogenesis Assay-Xenopus,
9'Qfn or FETAX. Haseman takes
pride in offering an unbi-
ased analysis. "The develop-
ers of these tests want them
adopted, sometimes very badly," he says.
"I see it as my job to make certain that
the statistical methodology utilized in
these new models is appropriate and that
the data are correctly evaluated and
interpreted."
Although eligible to retire after
more than 30 years of government ser-
vice, Haseman is in no hurry. 'I really
enjoy my job, and the people at the
institute are great to work with," he
says. "I am one of those unusual indi-
viduals who loves working with num-
bers and large databases, and I certainly
have plenty of opportunity for this at
the NIEHS. As long as my job contin-
ues to be fun, I may be around for a
long time." -John Manuel
studies typically last only one-fourth as long and oaredtostandardrodentbioassays.
NTP MayTest
Cell Phones
At its 30 June 2000 meeting,
the Executive Committee of
the National Toxicol-
ogy Program (NTP)
approved a recom-
mendation for the NTP
to study radio frequency radiation
emissions from wireless communica-
tion devices, which include cellular
phones. The NTP is currently evaluat-
ing the need, feasibility, and scope
ofa possible testing program.
The recommendation came from
the Food and Drug Administration,
which regulates electronic products
that emit radiation. The administra-
tion noted in its nomination that in
the United States alone over 80 mil-
lion people currently use portable
communication devices, with about
25,000 new users daily.
Cell phones use low-level micro-
wave radiation to communicate
between the caller and a base sta-
tion. If tissues are exposed to strong
enough microwave fields, the rise in
tissue temperature can cause well-
documented thermal effects such as
cataracts, deep-tissue burns, and
heat stroke. Cell phones are current-
ly required to meet exposure guide-
lines established by the Federal
Communications Commission to pro-
tect against acute injury from ther-
mal effects. However, nonthermal
effects, which occur at much lower
levels of exposures, are neither well
established nor, consequently, pro-
tected against through regulation.
Some research has suggested that
such microwave radiation may influ-
ence DNA synthesis and tumor
growth through unspecified ways.
It is widely agreed by scientists
that more research is needed before
any firm conclusions can be drawn
regarding the human health effects
of cell phone use. Scott Masten,
head ofthe Offke of Chemical Nom-
ination and Selection, which coordi-
nates and reviews nominations for
NTP studies, says, 'The public health
concern and public health awareness
about potential hazards of cell
phone use is very clear. There's also a
great deal of research effort globally
on the health effects of radio fre-
quency radiation emissions from
wireless communication devices. Just
the number of people exposed
worldwide would make it a poten-
tial public health problem if any
adverse effects were to be identi-
fied." -Susan M. Booker
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